We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drug products failing to meet established specifications are not rejected.
Even though this observation was previously cited, on 9/25/2009, no further action was taken by the Quality Unit regarding the following 23 finished product lots which were manufactured using failing components.